NasdaqGS - Nasdaq Real Time Price USD
Cabaletta Bio, Inc. (CABA)
1.6954
+0.3954
+(30.42%)
As of 1:08:36 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-88,222
-88,222
-53,549
-46,380
-34,109
Investing Cash Flow
47,289
47,289
-22,451
-27,217
5,999
Financing Cash Flow
11,677
11,677
187,631
32,982
48,903
End Cash Position
163,962
163,962
193,238
81,607
122,222
Interest Paid Supplemental Data
748
748
0
--
--
Capital Expenditure
-2,211
-2,211
-687
-2,453
-1,166
Issuance of Capital Stock
10,875
10,875
185,202
32,855
48,253
Repayment of Debt
-897
-897
0
--
--
Free Cash Flow
-90,433
-90,433
-54,236
-48,833
-35,275
12/31/2021 - 10/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYTX Kyverna Therapeutics, Inc.
2.1600
+0.47%
FATE Fate Therapeutics, Inc.
1.0050
+4.69%
VOR Vor Biopharma Inc.
0.1737
+1.58%
ALXO ALX Oncology Holdings Inc.
0.4319
-5.99%
TNYA Tenaya Therapeutics, Inc.
0.3732
-3.78%
ZNTL Zentalis Pharmaceuticals, Inc.
1.1950
+0.42%
AUTL Autolus Therapeutics plc
1.2500
+2.46%
TNGX Tango Therapeutics, Inc.
1.3850
+7.78%
NKTX Nkarta, Inc.
1.7150
-8.29%
LXEO Lexeo Therapeutics, Inc.
2.6350
-2.04%